Literature DB >> 10029610

Assessing activity of pediatric Crohn's disease: which index to use?

A Otley1, H Loonen, N Parekh, M Corey, P M Sherman, A M Griffiths.   

Abstract

BACKGROUND & AIMS: The Pediatric Crohn's Disease Activity Index (PCDAI) is a multi-item measure that, in contrast to the adult-derived CDAI, includes linear growth and places less emphasis on subjectively reported symptoms but more on laboratory parameters of intestinal inflammation. This study compared the feasibility, validity, and responsiveness of PCDAI vs. CDAI in the assessment of Crohn's disease activity among pediatric patients.
METHODS: Eighty-one children and adolescents with Crohn's disease were studied. A gastroenterologist provided a categorical global assessment of disease activity as quiescent, mild, moderate, or severe after interview and physical examination. CDAI and PCDAI scores were calculated by an independent appraiser.
RESULTS: Mean values within each category for CDAI and PCDAI differed significantly between strata. PCDAI values were quiescent, 6.8 +/- 6. 6; mild, 18.7 +/- 7.3; moderate, 38.5 +/- 12.9; and severe, 54.2 +/- 14.0. CDAI values were quiescent, 23.5 +/- 53.6; mild, 96.0 +/- 60. 7; moderate, 184.5 +/- 97.0; and severe, 284.4 +/- 85.8. Individual scores showed less overlap between strata for PCDAI than for CDAI. PCDAI showed better correlation with serum orosomucoid and platelet count, laboratory parameters of inflammation not included in either index.
CONCLUSIONS: Both PCDAI and CDAI reflect disease activity in pediatric Crohn's disease. PCDAI is better at discriminating between levels of disease activity.

Entities:  

Mesh:

Year:  1999        PMID: 10029610     DOI: 10.1016/s0016-5085(99)70173-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  Longer-term outcomes of nutritional management of Crohn's disease in children.

Authors:  B Lambert; D A Lemberg; S T Leach; A S Day
Journal:  Dig Dis Sci       Date:  2012-06-02       Impact factor: 3.199

2.  Efficacy of early treatment with infliximab in pediatric Crohn's disease.

Authors:  Jong Seung Lee; Jee Hyun Lee; Ji Hyuk Lee; Hye Jin Lee; Mi Jin Kim; Hae Jeong Lee; Yon Ho Choe
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

3.  Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved.

Authors:  Nadeem A Afzal; Sue Davies; Morine Paintin; Franck Arnaud-Battandier; John A Walker-Smith; Simon Murch; Robert Heuschkel; John Fell
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Short pediatric Crohn's disease activity index for quality improvement and observational research.

Authors:  Michael D Kappelman; Wallace V Crandall; Richard B Colletti; Anthony Goudie; Ian H Leibowitz; Lynn Duffy; David E Milov; Sandra C Kim; Bess T Schoen; Ashish S Patel; John Grunow; Evette Larry; Gerry Fairbrother; Peter Margolis
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

5.  Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.

Authors:  Kevin A Hommel; Robert N Baldassano
Journal:  J Pediatr Psychol       Date:  2009-12-21

6.  Intestinal lesions in pediatric Crohn disease: comparative detectability among pulse sequences at MR enterography.

Authors:  Beomseok Sohn; Myung-Joon Kim; Hong Koh; Kyung Hwa Han; Mi-Jung Lee
Journal:  Pediatr Radiol       Date:  2014-03-02

7.  Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease.

Authors:  Kevin A Hommel; Christine M Davis; Robert N Baldassano
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

8.  Growth hormone treatment for growth failure in pediatric patients with Crohn's disease.

Authors:  Melvin B Heyman; Elizabeth A Garnett; Janet Wojcicki; Neera Gupta; Cheryl Davis; Stanley A Cohen; Benjamin D Gold; Barbara S Kirschner; Robert N Baldassano; George D Ferry; Harland S Winter; Selna Kaplan
Journal:  J Pediatr       Date:  2008-06-27       Impact factor: 4.406

9.  Medication adherence and quality of life in pediatric inflammatory bowel disease.

Authors:  Kevin A Hommel; Christine M Davis; Robert N Baldassano
Journal:  J Pediatr Psychol       Date:  2008-03-11

10.  Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI.

Authors:  V A Pupillo; E Di Cesare; G Frieri; N Limbucci; M Tanga; C Masciocchi
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.